Mohit Butaney
223 works · 8,344 citations · h-index 28
Top works
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- Dissemination of Misinformative and Biased Information about Prostate Cancer on YouTube
- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
- Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
- Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions
- The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with EGFR Mutations
- Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer
- The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer
- Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
- ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas
- Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers
- Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers
- Delay of chemotherapy through use of post-progression erlotinib in patients with EGFR-mutant lung cancer.
- A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
- Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS -Mutant Lung Adenocarcinoma
- Quality of Bladder Cancer Information on YouTube